Dr Lisa Lancaster Discusses the Overlap of Sleep Apnea and Lung Diseases

Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health, discusses how sleep apnea is a comorbidity for other lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease.

Related Videos

Related Content

Advertisement

November 21st 2024

Elevating Value in Cancer Care With Innovations, Accessibility, Equity

Cameron Santoro

Coverage from the IVBM Regional event in Denver, Colorado.

November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi

The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.

November 21st 2024

Treating Double-Exposed Patients With CLL: A Continued Unmet Need

Gayle Turim Dickstein

For patients with chronic lymphocytic leukemia (CLL) treated previously with venetoclax and Bruton’s tyrosine kinase inhibitors, many more trials are needed to pinpoint the best next steps

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.

November 21st 2024

Research Priorities Evolve With Amivantamab's Broader NSCLC Indications

Maggie L. Shaw

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat non–small cell lung cancer (NSCLC).

Related Content

Advertisement

November 21st 2024

Elevating Value in Cancer Care With Innovations, Accessibility, Equity

Cameron Santoro

Coverage from the IVBM Regional event in Denver, Colorado.

November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi

The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.

November 21st 2024

Treating Double-Exposed Patients With CLL: A Continued Unmet Need

Gayle Turim Dickstein

For patients with chronic lymphocytic leukemia (CLL) treated previously with venetoclax and Bruton’s tyrosine kinase inhibitors, many more trials are needed to pinpoint the best next steps

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.

November 21st 2024

Research Priorities Evolve With Amivantamab's Broader NSCLC Indications

Maggie L. Shaw

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat non–small cell lung cancer (NSCLC).